As a benefit for attending the 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC) provides enduring materials free of charge for the specific programs attended. If you are a SITC member, or member of the general public,...
The 4th annual NeoAg Summit is returning to Boston this November to provide your team with one all-inclusive forum to successfully target tumor-specific neoantigens and bring to market personalized cancer vaccines and cellular therapies. More.
A multi-professional platform for oncology education and exchange, and for immense international visibility for scientific research, this year the Congress featured a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS). ...
Oxford Global’s R&D US Series features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarkers & Precision Medicine USA Congress, and fast-emerging Advances in Immuno-Oncology USA Congress....
The future of immuno-oncology drug development is positioned in combination therapies, where immunotherapy modalities are tested in rational combinations with other immunotherapies or targeted therapies for synergistic effects. Combination immunotherapy promises to...